See a recap of our Q1 2024 #earnings here: social.jnj.com/4cZxOHd $JNJ

Joe Wolk, Executive Vice President and Chief Financial Officer, #JNJ , on our Q1 2024 #earnings and financial performance. $JNJ

Joaquin Duato, Chairman of the Board and Chief Executive Officer, #JNJ , on our Q1 2024 #earnings and financial performance. $JNJ

Join our Q1 2024 #earnings call and webcast now: social.jnj.com/3xxGzYQ $JNJ

New: We’ve announced our Q1 2024 performance results. See the release for full financial details and non-GAAP reconciliations: social.jnj.com/3xDhonJ $JNJ #earnings

Join us tomorrow at 8:30 AM ET for a live call and webcast as we share our Q1 2024 results. Register here: social.jnj.com/3UeDYuL $JNJ #earnings

This #WorldHealthDay , see how we’re continuing our pledge to foster health equity, empower our healthcare workers, and improve healthcare accessibility for all: social.jnj.com/49toYhS

#JNJ is proud to announce an agreement to acquire Shockwave Medical, a pioneer in the development of transformational technologies for the treatment of cardiovascular disease. Click here for key information and cautionary statements: social.jnj.com/3xwStlz

Ending racial health inequities takes all of us.​

We’re teaming up with more than 100 organizations working to improve care for U.S. communities of color. ​Read more: social.jnj.com/3U1tZda #NMHM2024

We’re honored to be named to FORTUNE's America’s 2024 Most Innovative Companies list. Explore how our commitment to innovation has earned us a spot on the second annual list: social.jnj.com/3VBnMGa

More efficient surgery. Potential for quicker recovery. Explore how we’ve streamlined reverse shoulder replacement surgery with a new system designed to offer surgeons flexibility in the operating room and improve patient outcomes: social.jnj.com/3uK1Hu2

Could we be on our way to eliminating cancer? Our team shared the innovative approaches we are developing to advance diagnosis and treatment options for everyone, everywhere: social.jnj.com/3uR9FRZ

The future of healthcare is here. We're headed to #SXSW with the latest innovative technology—from VR health simulations and robotic surgery to retinal disease and psoriatic arthritis patient journeys.

Did you know: Black Americans are 4x more likely to undergo an amputation due to peripheral artery disease (PAD). J&J Innovative Medicine's Dr. Richard Browne speaks with ABC News Live about the impact PAD can have on the Black community and how we’re working to advance equitable care:…

Intestinal worms affect 898M children each year.

Through our longstanding commitment to #BeatNTDs , we intend to extend our intestinal worm medicine donations through 2030. Distributing up to 1B more doses will help more kids grow & thrive. jnj.com/press-releases…… #WorldNTDDay

Our scientists are developing new ways to treat depression based on each patient's unique symptoms. See how we’re advancing precision psychiatry: social.jnj.com/490ukSg

Improving maternal care includes screening for diseases such as fetal and neonatal alloimmune thrombocytopenia (FNAIT), which can lead to bleeding and death in newborns.

Read one family's story and how we're aiming to deliver new approaches. bit.ly/3vN4RNB

See a recap of our Q4 2023 and full-year #earnings here: social.jnj.com/3vUq7AX $JNJ

Joe Wolk, Executive Vice President and Chief Financial Officer, #JNJ , on our Q4 2023 #earnings and full-year financial performance. $JNJ

Joaquin Duato, Chairman and Chief Executive Officer, #JNJ , on our Q4 2023 #earnings and full-year financial performance. $JNJ